Myocardial hypertrophy is associated with inflammation and activation of endocannabinoid system in patients with aortic valve stenosis

Life Sciences

Volumn 92, Issue 20-21, 2013, Pages 976-983

  Duerr, Georg D ^a   Heinemann, Jan C ^a   Dunkel, Silke ^a   Zimmer, Andreas ^b   Lutz, Beat ^c   Lerner, Raissa ^c   Roell, Wilhelm ^a   Mellert, Fritz ^a   Probst, Chris ^a   Esmailzadeh, Bahman ^a   Welz, Armin ^a   Dewald, Oliver ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Endocannabinoids; Inflammation; Myocardial hypertrophy; Remodeling

Indexed keywords

ANANDAMIDE; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CONNECTIVE TISSUE GROWTH FACTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TENASCIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; AORTA VALVE STENOSIS; ARTICLE; CARDIAC PATIENT; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HEART ATRIUM MYXOMA; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MALE; MYOFIBROBLAST; PROTEIN LOCALIZATION;

AGED; AORTIC VALVE STENOSIS; CARDIOMEGALY; ENDOCANNABINOIDS; FEMALE; HUMANS; INFLAMMATION; MALE;

EID: 84877754731     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.03.014     Document Type: Article

References (28)

1. S. Batkai, P. Mukhopadhyay, J. Harvey-White, R. Kechrid, P. Pacher, and G. Kunos Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats Am J Physiol Heart Circ Physiol 293 2007 H1689 H1695
2. O. Dewald, N.G. Frangogiannis, M. Zoerlein, G.D. Duerr, C. Klemm, and P. Knuefermann Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species Proc Natl Acad Sci U S A 100 2003 2700 2705
3. O. Dewald, P. Zymek, K. Winkelmann, A. Koerting, G. Ren, and T. Abou-Khamis CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts Circ Res 96 2005 881 889
4. M. Fluck, S.I. Mund, J.C. Schittny, S. Klossner, A.C. Durieux, and M.N. Giraud Mechano-regulated tenascin-C orchestrates muscle repair Proc Natl Acad Sci U S A 105 2008 13662 13667
5. N.G. Frangogiannis, S. Shimoni, S.M. Chang, G. Ren, O. Dewald, and C. Gersch Active interstitial remodeling: an important process in the hibernating human myocardium J Am Coll Cardiol 39 2002 1468 1474
6. N.G. Frangogiannis, S. Shimoni, S.M. Chang, G. Ren, K. Shan, and C. Aggeli Evidence for an active inflammatory process in the hibernating human myocardium Am J Pathol 160 2002 1425 1433
7. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, and V. Polyakova Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
8. S. Heymans, B. Schroen, P. Vermeersch, H. Milting, F. Gao, and A. Kassner Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart Circulation 112 2005 1136 1144
9. C.Y. Ho, B. Lopez, O.R. Coelho-Filho, N.K. Lakdawala, A.L. Cirino, and P. Jarolim Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 363 2010 552 563
10. N. Koitabashi, M. Arai, S. Kogure, K. Niwano, A. Watanabe, and Y. Aoki Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis Hypertension 49 2007 1120 1127
11. F. Kuwahara, H. Kai, K. Tokuda, M. Takeya, A. Takeshita, and K. Egashira Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43 2004 739 745
12. P. Lepicier, J.F. Bouchard, C. Lagneux, and D. Lamontagne Endocannabinoids protect the rat isolated heart against ischaemia Br J Pharmacol 139 2003 805 815
13. Y. Liao, J. Bin, M. Asakura, W. Xuan, B. Chen, and Q. Huang Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice Eur Heart J 30 2011 3124 3133
14. M. Mundhenke, B. Schwartzkopff, and B.E. Strauer Structural analysis of arteriolar and myocardial remodelling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy Virchows Arch 431 1997 265 273
15. Y. Naito, T. Tsujino, H. Akahori, M. Ohyanagi, M. Mitsuno, and Y. Miyamoto Augmented cannabinoid receptors expression in human aortic valve stenosis Int J Cardiol 145 2010 535 537
16. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodelling Lancet 367 2006 356 367
17. A.N. Panek, M.G. Posch, N. Alenina, S.K. Ghadge, B. Erdmann, and E. Popova Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload PLoS One 4 2009 e6743
18. P. Razeghi, M.F. Essop, J.M. Huss, S. Abbasi, N. Manga, and H. Taegtmeyer Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart Biochem Biophys Res Commun 303 2003 1024 1027
19. K. Schulte, N. Steingruber, B. Jergas, A. Redmer, C.M. Kurz, and R. Buchalla Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor Naunyn Schmiedebergs Arch Pharmacol 385 2012 385 396
20. S. Steffens, N.R. Veillard, C. Arnaud, G. Pelli, F. Burger, and C. Staub Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice Nature 434 2005 782 786
21. A. Tamura, S. Kusachi, K. Nogami, A. Yamanishi, Y. Kajikawa, and S. Hirohata Tenascin expression in endomyocardial biopsy specimens in patients with dilated cardiomyopathy: distribution along margin of fibrotic lesions Heart 75 1996 291 294
22. P. Teekakirikul, S. Eminaga, O. Toka, R. Alcalai, L. Wang, and H. Wakimoto Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta J Clin Invest 120 2010 3520 3529
23. F. Terasaki, H. Okamoto, K. Onishi, A. Sato, H. Shimomura, and B. Tsukada Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy Circ J 71 2007 327 330
24. M. Vanderheyden, W. Mullens, L. Delrue, M. Goethals, B. de Bruyne, and W. Wijns Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders J Am Coll Cardiol 51 2008 129 136
25. A.V. Villar, M. Cobo, M. Llano, C. Montalvo, F. Gonzalez-Vilchez, and R. Martin-Duran Plasma levels of transforming growth factor-beta1 reflect left ventricular remodeling in aortic stenosis PLoS One 4 2009 e8476
26. B. Villari, S.E. Campbell, O.M. Hess, G. Mall, G. Vassalli, and K.T. Weber Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease J Am Coll Cardiol 22 1993 1477 1484
27. F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, and A. Beiras Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J Mol Cell Cardiol 48 2010 1187 1193
28. Y. Xia, K. Lee, N. Li, D. Corbett, L. Mendoza, and N.G. Frangogiannis Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload Histochem Cell Biol 131 2009 471 481